Showing results (1431-1440 of 2,818) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|April 15, 2011
An ultraviolet-spectrophotometric method for the determination of glimepiride in solid dosage formsOzadheoghene E Afieroho, Ogbonna Okorie, Tochukwu J N OkonkwoDiabetes Technology & Therapeutics|March 19, 2011
Modeling the consistency of hypoglycemic symptoms: high variability in diabetesNicola N Zammitt, George Streftaris, Gavin J Gibson, et al.Diabetes Technology & Therapeutics|March 17, 2011
The effect of liraglutide added to U-500 insulin in patients with type 2 diabetes and high insulin requirementsWendy Lane, Stephen Weinrib, Jonathan RappaportDiabetes Technology & Therapeutics|March 17, 2011
A Chinese diabetes risk score for screening of undiagnosed diabetes and abnormal glucose toleranceMin Liu, Changyu Pan, Mengmeng JinDiabetes Technology & Therapeutics|March 17, 2011
Novel hormonal delivery method using the ink-jet technology: application to pulmonary insulin therapiesMasami Nemoto, Yoshito Hiki, Kousuke Shimada, et al.Diabetes Technology & Therapeutics|March 2, 2011
Lowering postprandial glycemia in children with type 1 diabetes after Italian pizza "margherita" (TyBoDi2 Study)Alessandra De Palma, Elisa Giani, Dario Iafusco, et al.Diabetes Technology & Therapeutics|March 2, 2011
Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetesRonald J Pettis, Laurence Hirsch, Christoph Kapitza, et al.Diabetes Technology & Therapeutics|March 2, 2011
Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjectsJyoti Gupta, Eric I Felner, Mark R PrausnitzDiabetes Technology & Therapeutics|March 2, 2011
Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injectionRonald J Pettis, Barry Ginsberg, Laurence Hirsch, et al.Diabetes Technology & Therapeutics|March 2, 2011
Recovery of β-cell functions with low-dose insulin therapy: study in newly diagnosed type 2 diabetes mellitus patientsSaptarshi Bhattacharya, Ariachery C Ammini, Viveka Jyotsna, et al.Pageof 282